Home › Trial NCT03297463
Radiation Therapy With Combination Immunotherapy for Relapsed/Refractory Metastatic Melanoma
- Trial IDNCT03297463
- StatusWithdrawn
- PhasePhase 1/2
- Study typeInterventional
- SponsorMasonic Cancer Center, University of Minnesota
- Enrollment—
- Start date2018-01-31
- ConditionsMetastatic Melanoma · Pulmonary Metastases · Hepatic Metastases · Brain Metastases
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.